Topic

Aetna (CVS Health)

A collection of 1140 issues

Getting Breyanzi (Lisocabtagene Maraleucel) Covered by Aetna CVS Health in Ohio: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Breyanzi Covered by Aetna CVS Health in Ohio Breyanzi (lisocabtagene maraleucel) requires mandatory prior authorization from Aetna CVS Health before coverage. To qualify, you need confirmed relapsed/refractory large B-cell lymphoma after ≥2 prior therapies, ECOG performance status 0-2, and treatment at a certified CAR-T center. First
7 min read

Work With Your Doctor to Get Epidiolex (Cannabidiol) Covered by Aetna CVS Health in California: Complete Prior Authorization Guide

Quick Answer: Getting Epidiolex Covered by Aetna CVS Health in California Epidiolex requires prior authorization through Aetna CVS Health for seizures in Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. Your neurologist must submit documentation showing failed trials of other anti-seizure medications. If denied, you can appeal within 180 days
7 min read

How to Get Gattex (Teduglutide) Covered by Aetna CVS Health in Virginia: Forms, Appeals, and Provider Resources

Answer Box: Getting Gattex Covered by Aetna CVS Health in Virginia Eligibility: Adults with short bowel syndrome dependent on parenteral nutrition ≥12 months, receiving support ≥3 times weekly. Fastest path: Submit prior authorization through Aetna provider portal with baseline parenteral nutrition logs and specialist attestation. Start today: Call CVS Specialty
6 min read

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by Aetna CVS Health in Michigan: Complete Guide to Prior Authorization, Appeals, and External Review

Quick Answer: Getting Xywav Covered by Aetna CVS Health in Michigan Xywav (calcium/magnesium/potassium/sodium oxybates) requires prior authorization from Aetna CVS Health before dispensing. You'll need REMS enrollment, documentation of narcolepsy or idiopathic hypersomnia diagnosis, and proof of step therapy completion (modafinil/armodafinil trials). Standard decisions
6 min read